The ageing population has resulted in an increase in multimorbidity and polypharmacy, and subsequently the complexity of optimising elderly patients’ medicines. The need for deprescribing can arise from factors such as increased susceptibility to adverse effects of medicines in older age, due to functional and cognitive changes, which increases elderly people’s risk of harm. Previous questionnaire-survey-based research suggests that patients tend not to disagree with deprescribing, but qualitative research on patients’ perspectives on deprescribing appears sparse and focused on specific conditions, circumstances (e.g., terminal illness) or medicines. Further exploration of this area is therefore important for health professionals, and great...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
Summary: Background: Elderly are mostly affected by polypharmacy induced adverse drug events as the...
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 Internationa...
The ageing population has resulted in an increase in multimorbidity and polypharmacy, and subsequent...
The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes t...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
Last month, the research roundup provided you with an overview of articles looking at polypharmacy a...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
peer reviewed[en] INTRODUCTION: To reduce inappropriate polypharmacy, deprescribing should be part o...
BACKGROUND Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of ...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
The increase in the number of medications used may result many negative consequences for patients an...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
Summary: Background: Elderly are mostly affected by polypharmacy induced adverse drug events as the...
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 Internationa...
The ageing population has resulted in an increase in multimorbidity and polypharmacy, and subsequent...
The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes t...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
Last month, the research roundup provided you with an overview of articles looking at polypharmacy a...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
peer reviewed[en] INTRODUCTION: To reduce inappropriate polypharmacy, deprescribing should be part o...
BACKGROUND Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of ...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
The increase in the number of medications used may result many negative consequences for patients an...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
Summary: Background: Elderly are mostly affected by polypharmacy induced adverse drug events as the...
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 Internationa...